A Health Canada review has deemed cannabidiol (CBD) “safe and tolerable” for short-term use in dosages ranging from 20 milligrams per day up to 200 mg/day.
For consumers who take CBD for more than 30 days, the review suggests a health care practitioner should be consulted.
The review also determined that CBD is not habit-forming, reflecting a “similar finding reached in a recent CBD review done by an expert committee of the World Health Organization” (WHO).
“The WHO expert committee identified CBD as non-addictive, not associated with potential human abuse and found no case reports of abuse or dependence related to pure CBD,” the review notes.
The Canadian advisory committee agreed unanimously that there is some early evidence that CBD may be effective for the short-term treatment of mild symptoms associated with stress and nervousness.
Members further agreed that there is a lack of
Read full article on The Growth Op
